• Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
Research & Innovation that Transforms Care
10 May 2020

Did you know that there are currently 38 clinical studies and researches being carried out at Pantai Hospital Kuala Lumpur to improve quality of care and clinical outcomes? These are driven by none other than Malaysia Operation’s first Research & Innovation Department set up in November last year.

Senior Research Scientist Dr Wong Shin Yee, a PhD holder in Molecular Medicine, heads the new department, supported by a team of experienced study coordinators and research assistants. For months now, they have been working with different stakeholders on the 38 approved studies that span multiple medical fields.

Cancer therapy is the current research focus, with 14 oncology clinical trials underway relating to breast cancer and non-small cell lung carcinoma. In addition, there are five oncology studies initiated by the consultants at Pantai Hospital Kuala Lumpur to determine the clinical outcomes of cancer patients at Pantai Hospital Kuala Lumpur.

The team is making good headway and looks forward to share their research outcomes soon. Stay tuned.

Related Stories

IHH GCEO Global Town Hall 9Feb2026 Thumbnail

2026 IHH Global Town Hall: Building a Future-ready Workforce

'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.

10 May 2020
Read More
Thumbnail IHH Malaysia Partners Libyan Government for Medical Referrals

IHH Malaysia Partners Libyan Government for Medical Referrals

IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.

10 May 2020
Read More

Agilus Diagnostics Expands Access to Next-Generation Precision Genomics

Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India. 

10 May 2020
Read More

Parkway Shanghai Opens International Centre for Hepatobiliary and Pancreatic Diseases

Held on 21 January, the 2026 Parkway Shanghai International Forum on Hepatobiliary and Pancreatic Diseases brought together leading experts from Mainland China and Hong Kong to share the latest developments in hepatobiliary and pancreatic surgery.
10 May 2020
Read More

Mount Elizabeth Hospitals Celebrate 97 Wins at Singapore Health Quality Service Awards 2026

Mount Elizabeth Hospitals Orchard and Novena have been recognised for their unwavering commitment to clinical excellence and patient-centred care at the Singapore Health Quality Service Awards (SHQSA) 2026, organised by SingHealth.
10 May 2020
Read More

Celebrating the People of Gleneagles Hong Kong

A special animation, Your Touch, Our Glow, narrated by the CEO of Gleneagles Hospital Hong Kong, Dr Kenneth Tsang, was created as a tribute to its people. The animation introduces three caring companions designed especially for staff, collectively known as the #GleneaglesBuddies.
10 May 2020
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Parkway Radiology Logo
  • Acibadem Labmed Logo
  • Parkway Laboratories Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo